Supplementary Journal Content

To conserve space in the printed Journal, additional supplementary materials are made available here. Locate the issue and select the additional material link to download the files.

• Sep/Oct 2024

  Tables for Safer Sterile Compounding - Choosing and Using Disinfectants for the Cleanroom.pdf.

• May/Jun 2024

  Questionnaire for A Cross-sectional Online Questionnaire-based Survey About the Use of Compounded Medications in Veterinary Ophthalmology.

  See also Google Docs online version.

• Jan/Feb 2024

  Tables for Safer Sterile Compounding: Choosing and Using Disinfectants for the Cleanroom.

• Sep/Oct 2023

  References for Povidone Iodine Lotion formulation.

• July/Aug 2023

  References for Trihexyphenidyl Hydrochloride 1-mg per mL Oral Liquid, Alcohol-free formulation.

  References for Clotrimazole 1% and Betamethasone Dipropionate 0.05% Cream formulation.

  References for Rifampin 10-mg per mL Nasal Drops formulation.

  References for Chlorhexidine and Cetrimide Lotion formulation.

• May/Jun 2023

  Suspension preparation videos for An Alternative Approach to Tablet Splitting and Grinding for Medication Administration.

  References for Nystatin Oromucosal Viscous Suspension formulation.

• Mar/Apr 2023

  References for Aminohippurate Sodium 250 mg-mL Injections formulation.

  References for Cyclosporine Topical Microemulsion formulation.

• Jan/Feb 2023

  References for Psoriasis Topical Ointment formulation.

• Sep/Oct 2022

  References for Ascorbic Acid 5% Topical Microemulsion formulation.

• Jul/Aug 2022

  References for Psoriasis Topical Ointment formulation.

  Updated photos in Evaluation of the Physical-chemical Characteristics and Biopharmaceutical Performance of Dilu-Cap: A Complete Line of Excipients for Hard-shell Capsules.

• May/Jun 2022

  References for four formula in this issue.

• Mar/Apr 2022

  References for Ketoconazole 2% Terbinafine 1% Acetic Acid 2% and Urea 2% in Dimethyl Sulfoxide Nail Polish.

  References for Mesalamine 100-mg per mL Suspension Enema.

• Mar/Apr 2021

  References for Descriptive Report of Inpidual State Responses to Personal Protective Equipment Shortages for Pharmacy Practice During the Covid-10 Pandemic.

• Jan/Feb 2021

  Erratum for Physical Compatibility of Cefiderocol with Selected Intravenous Drugs During Simulated Y-site Administration.

• Sep/Oct 2020

  References for Ketamine Acepromazine and Xylazine and Ketamine formulations.

• Jul/Aug 2020

  Erratum for Stability of Extemporaneous Oral Tramadol, Fluoxetine, and Doxycycline Suspensions in SyrSpend SF PH4.

• May/Jun 2020

  Addendum to Compounded Beta-blocker Nasal Spray for Treatment of Acute Migraine: A New Therapeutic Modality.

• Nov/Dec 2019

  Erratum for How to Qualify Container Closure Systems for Intended Use-Part 1.

• Sep/Oct 2019

  References for Oral Viscous Sucralfate Gel for Post-procedural Treatment of Barrett's Esophagus.

• Jul/Aug 2019

  Supplemental Content for Subcutaneous Testosterone Anastrozole Therapy in Men-Rationale Dosing and Levels on Therapy.

• May/Jun 2019

  Erratum for Trends of Extemporaneous Drug Prescription in Latvia in 2017.

  Erratum for Summary of Educational Offerings Provided by Compounding Support Companies in 2019.

• Mar/Apr 2019

  Erratum for Topical Treatment of Primary Focal Hyperhidrosis-Part 2.

  Replaced Rosuvastatin 20 mg/mL Oral Suspension with Rosuvastatin 20-mg/5-mL Oral Suspension due to corrections made to original sources. Please see references note for more information.

• Sep/Oct 2018

  PCH Certification Form and Explanation for Certification of Powder-containment Hoods for Nonsterile Compounding.

  Online Tables for Compounding Enclosures: Ensuring Safety During the Preparation of Sterile and Nonsterile Formulations.

• Nov/Dec 2017

  References for Trace Elements Injection 5.

• May/Jun 2017

  Competency Assessment Form for Counting Colonies on Growth Media

• Sep/Oct 2016

  References for Menopausal Symptom Relief and Side Effects Experienced by Women Using Compounded Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 1.

• Mar/Apr 2016

  References for Topical Ketamine: A Review of the History Mechanisms, Uses, Safety, and Future.

• Nov/Dec 2015

  References for Applying Quality by Design Concepts to Pharmacy Compounding.

• 8/7/2015 CompoundingToday.com Newsletter

  Nominations of Difficult to Compound Drugs to the FDA-PCAC.

• Jul/Aug 2015

  Tables for Safer Sterile Compounding: Choosing and Using Disinfectants for the Cleanroom.

• May/June 2015

  Formulations for Basics of Compounding: Compounding with Silicones.

• March/April 2015

  Reference tables from USP <797> cited in New England Compounding Center Indictment.

  Additional tables and figure for Quality Assurance and Quality Control, Part 1.

• January/February 2015

  About the Authors of Agar Transfer Devices for Environmental Sampling in the Compounding Pharmacy.

  List of Drugs Withdrawn or Removed from Market from The Revised "Not to Compound" List.

  Table of Stabilizing Agents for Biotechnology Preparations from Biotechnology, Nanotechnology, and Pharmacogenomics and Pharmaceutical Compounding, Part 1

• November/December 2014

  Tables and figures for for Depyrogenation Options for the Compounding Cleanroom

• September/October 2014

  Additional figures for Compounding Practices in a Portuguese Community Pharmacy

• July/August 2014

  Sidebar tables for Vial Washers for the Compounding Pharmacy: Ensuring Preparation Safety

• May/June 2014

  Additional hospice formulations for Compounded Drugs of Value in Outpatient Hospice and Palliative Care Practice
  Powerpoint presentation of customer appreciation letters to go with Compounded Drugs of Value in Outpatient Hospice and Palliative Care Practice

• November/December 2013

  Slide show presentations from : Improving the Review of Standard Operating Procedures: A Novel Electronic System for Compounding Pharmacies
  How to Email an SOP Quiz - Adobe Acrobat (.pdf) Format, 590 kb
  How to Email an SOP Quiz - Microsoft Powerpoint (.pptx) Format, 805 kb

  How to Grade an SOP Quiz - Adobe Acrobat (.pdf) Format, 946 kb
  How to Grade an SOP Quiz - Microsoft Powerpoint (.pptx) Format, 646 kb

• January/February 2013

  Microsoft Excel spreadsheet for "Compounding Slow-release Capsules: A Comprehensive Review and an Excel Spreadsheet for Faster Calculation of Excipients", page 10. Please note that the file contains three spreadsheet pages.

  Errata

• September/October 2012 (Vol. 16, No. 5)

  Suggested Formulae to Deliver 11:1 T4:T3 to the Bloodstream Based on Oral Bioavailability and Commercially Available T4 Strengths

  Erratum for Compounded Oral Ketamine for Severe Depression, Anxiety, and Pain in a Hospice Patient with End-stage Chronic Obstructive Pulmonary Disease, Cardiopulmonary Failure, and Severe Renal Insufficiency: A Case Report.

• July/August 2012 (Vol. 16, No. 4)

  Noninclusive List of Drugs in Short Supply and Noninclusive List of Drugs Withdrawn from the Market for Drug Shortages & Discontinued Drugs: The Effects on Patients and Healthcare Providers

• November/December 2011 (Vol. 15, No. 6)

  Diaper Rash Patient Handout for Diaper Rash Relief: Common Sense Remedies and Treatments

• September/October 2011 (Vol. 15, No. 5)

  References for Infantile Hemangiomas, Part 1: Treatment with Oral Propranolol Hydrochloride

• November/December 2010 (Vol. 14, No. 6)

  References for Amitriptyline Hydrochloride 2%, Baclofen 5%, Ketamine Hydrochloride 5%, Ketoprofen 10% in Pluronic Lecithin Organogel pg 512.

• September/October 2010 (Vol. 14, No. 5)

  Supplement to Conservative Management of Chronic Kidney Disease in Cats - Recommendations for Veterinarians and Compounding Pharmacists, pg 482
  An additional 20 formulations have been added to the digital version of this article. Subscription and login required to download.

• May/June 2010 (Vol. 14, No. 3)

  ERRATUM - Lansoprazole Oral Susp Formula, pg 440

• September/October 2008 (Vol. 12, No. 5) - Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 9: Immediate-Use Compounded Sterile Preparations, pg 440

  Good Compounding Techniques for Compounding Immediate Use Compounded Sterile Preparations
  A printable chart listing the steps needed to compound immediate-use sterile preparations.

• May/June 2006 (Vol. 10, No. 3) - Hormone Replacement Therapy

  Patient Satisfaction Survey Form
  from Patient Satisfaction with Pharmacist Intervention and Consultation in Hormone Replacement Therapy: An Update, Page 187

  Computer Software Evaluation Checklist
  from Wise Buys: Choosing the Right Software for a Compounding Pharmacy, Page 213

• March/April 2004 (Vol. 8, No. 2) - Overview of USP Chapter <797>

  Detailing Your Compounding Specialty Practice-Part 2: The Presentation
  A zip file containing customizable Word documents and a PowerPoint presentation.

• July/August 2000 (Vol. 4, No. 4)

  Correction to Providing Positive Outcomes through Compounding for Animal Cancer Patients.

• January/February 1997 (Vol. 1, No. 1)

  Erratum for Stability of an Extemporaneously Formulated Levothyroxine Sodium Syrup Compounded from Commercial Tablets